Management Team
Dr. Thomas Wilckens, MD | Chief Executive Officer
Founder Precision Medicine & Big Data in Life Science on LinkendIn; Associate GLORAD Institute on R&D management St. Gallen/Shanghai; Associate deep innovation, Munich, serial entrepreneur
[stealth mode], PhD | Chief Scientific Officer
Former CSO at German biopharmaceutical company. Drug discovery and inflammation expert. Expert knowledge in pre-clinical as well as clinical drug discovery and development; serial entrepreneur
Dr. Alexander Manta | Chief Data Officer
former Head of Informatics, Roche
[stealth mode], PhD | Head of Diagnostics & Biobanking; SOPs
former VP leading immune diagnostics company
Founder Precision Medicine & Big Data in Life Science on LinkendIn; Associate GLORAD Institute on R&D management St. Gallen/Shanghai; Associate deep innovation, Munich, serial entrepreneur
[stealth mode], PhD | Chief Scientific Officer
Former CSO at German biopharmaceutical company. Drug discovery and inflammation expert. Expert knowledge in pre-clinical as well as clinical drug discovery and development; serial entrepreneur
Dr. Alexander Manta | Chief Data Officer
former Head of Informatics, Roche
[stealth mode], PhD | Head of Diagnostics & Biobanking; SOPs
former VP leading immune diagnostics company
Board of Directors
Dr. Thomas Wilckens, MD
CEO InnVentis
Günther Weber
CTO deep innovation Gmbh, former Head of Advanced Research Program Vodafone Group R&D
CEO InnVentis
Günther Weber
CTO deep innovation Gmbh, former Head of Advanced Research Program Vodafone Group R&D
Scientific Advisory Board
Prof. Mike Snyder, PhD
Professor and Chair of Genetics; Director, Stanford Center for Genomics and Personalized Medicine
John Ryals, PhD
President and CEO of Metabolon Inc.
Jürgen Schäfer
Founder/CEO CONRESO; 34+ years experience in clinical research
Dr. Nicolas Schauer
CEO & Founder Metabolomic Discoveries
Dr. Lutz Weber
Founder Ontochem, former Head New Technologies at Roche
Professor and Chair of Genetics; Director, Stanford Center for Genomics and Personalized Medicine
John Ryals, PhD
President and CEO of Metabolon Inc.
Jürgen Schäfer
Founder/CEO CONRESO; 34+ years experience in clinical research
Dr. Nicolas Schauer
CEO & Founder Metabolomic Discoveries
Dr. Lutz Weber
Founder Ontochem, former Head New Technologies at Roche
Strategic Advisory Board
Christian Isler
Director at PA Consulting Group, fmr. Global Head of Solution and Product Development, Pfizer Integrated Health
Dr. Ali Tinazli
Global Head of Healthcare and Life Sciences Strategy CTO Office - Strategy & Incubation, HP
Director at PA Consulting Group, fmr. Global Head of Solution and Product Development, Pfizer Integrated Health
Dr. Ali Tinazli
Global Head of Healthcare and Life Sciences Strategy CTO Office - Strategy & Incubation, HP
Dr. Ali Tinazli has a deep background in the science and business of biomedicine and healthcare. Ali has done extensive work in the field of molecular biology of aging and nanobiotechnology and has authored about 20 publications. He received his PhD in BioChemistry from J.W. Goethe University in Germany, and also studied business at UC, Berkeley’s Haas School of Business and MIT’s Sloan School of Management. After receiving his Ph.D., Ali was in Corporate Development at Applied Biosystems (now: Thermo Fisher) where he conducted technology scouting and in-licensing. From 2008-2015, Dr. Tinazli, built the biomedical consumables business at Sony DADC (part of SONY Corporation). As a member of the management team at Sony DADC BioSciences, he has headed as VP & Head of Business Development the Americas business based out of Cambridge, MA. In December 2015, Ali Tinazli joined HP’s CTOs office in Palo Alto (CA) and is leading the corporate-wide, global strategy for Healthcare and Life Sciences. In addition to his bioscience and industry domain experience, Ali brings strong entrepreneurial experience and hands-on knowledge of the biosciences start-up community. He currently sits on the Advisory Board of a bioinformatics/computer processor company, and serves as a Board Member at various start-up companies in the biomedical/digital health space
Partners
Metabolon Inc.
Metabolomics
Metabolomic Discoveries
Metabolomics
Ontochem
Knowledge Mining, Ontologies
Conreso
Clinical trial CRO
We have secured additional collaborations with leading HMOs and academic institutions in Israel and Germany.
Metabolomics
Metabolomic Discoveries
Metabolomics
Ontochem
Knowledge Mining, Ontologies
Conreso
Clinical trial CRO
We have secured additional collaborations with leading HMOs and academic institutions in Israel and Germany.